Literature DB >> 23341094

Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma.

Ching-Yin Ho1, Kee-Tak Chan, Pen-Yuan Chu.   

Abstract

Familial aggregation of nasopharyngeal carcinoma (NPC) has been widely reported. The excess risk is about 4-8-fold among first-degree relatives of NPC patients compared with those without a family history of the disease. We used nasopharyngoscopy and a narrow-band image system (NBI) to screen NPC high-risk patients and identify a good tool for the early detection of NPC in these high-risk groups. We recruited all available, affected blood relations of the patients. When NPC patients were more distant relatives, such as cousins, we recruited their shared second-degree relatives, such as unaffected aunts and uncles, to genetically connect the NPC cases. We performed transnasal endoscopy, first in white-light mode, then under the NBI system. There were two NBI patterns in NPC: microvascular proliferation and engorged blood vessels. The NBI pattern in normal nasopharyngeal mucosa was a regular cobblestone pattern. A prospective study included 211 asymptomatic members from 154 NPC families. We found four cases of NPC, all with a tumor stage of T1. In one patient (1/4), MRI revealed a 2-cm-diameter neck lymphadenopathy (N1). The correlation between conventional nasopharyngoscopy and NBI was very high (κ = 0.798, P = 0.000). In conclusions, NBI is not superior to conventional nasopharyngoscopy for the early detection of NPC in unaffected members of families with NPC history. The long-term follow-up is necessary in high-risk NPC patients. Further studies will be needed to determine which screening tool-conventional nasopharyngoscopy, NBI, or EB virus titer-is most effective.

Entities:  

Mesh:

Year:  2013        PMID: 23341094     DOI: 10.1007/s00405-013-2354-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  Letter: Familial aggregation in nasopharyngeal carcinoma.

Authors:  E H Williams; G de Thé
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

2.  Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma.

Authors:  D M Heng; J Wee; K W Fong; L G Lian; V K Sethi; E T Chua; T L Yang; H S Khoo Tan; K S Lee; K M Lee; T Tan; E J Chua
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

3.  Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.

Authors:  Ivan Weng Keong Tham; Shaojun Lin; Jianji Pan; Lu Han; Jiade J Lu; Joseph Wee
Journal:  Am J Clin Oncol       Date:  2010-06       Impact factor: 2.339

4.  Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.

Authors:  Anthony T C Chan; Mow-Ming Hsu; Boon C Goh; Edwin P Hui; Tsang-Wu Liu; Michael J Millward; Ruey-Long Hong; Jacqueline Whang-Peng; Brigette B Y Ma; Ka F To; Matthias Mueser; Nadia Amellal; Xiao Lin; Alex Y Chang
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

5.  Screening for family members of patients with nasopharyngeal carcinoma.

Authors:  Wai-Tong Ng; Tsz-Kok Yau; Raymond W H Yung; Wai-Man Sze; Abby H L Tsang; Ada L Y Law; Anne W M Lee
Journal:  Int J Cancer       Date:  2005-03-01       Impact factor: 7.396

6.  Nasopharyngeal carcinoma detected by narrow-band imaging endoscopy.

Authors:  Wen-Hung Wang; Yen-Chun Lin; Kam-Fai Lee; Hsu-Huei Weng
Journal:  Oral Oncol       Date:  2011-03-09       Impact factor: 5.337

7.  Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study.

Authors:  H Machida; Y Sano; Y Hamamoto; M Muto; T Kozu; H Tajiri; S Yoshida
Journal:  Endoscopy       Date:  2004-12       Impact factor: 10.093

8.  Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience.

Authors:  Anne W M Lee; W M Sze; Joseph S K Au; S F Leung; T W Leung; Daniel T T Chua; Benny C Y Zee; Stephen C K Law; Peter M L Teo; Stewart Y Tung; Dora L W Kwong; W H Lau
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

9.  Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.

Authors:  C Y Chen; F Han; C Zhao; L X Lu; Y Sun; X F Liu; T X Lu
Journal:  Br J Radiol       Date:  2009-06       Impact factor: 3.039

10.  Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites.

Authors:  Manabu Muto; Mari Nakane; Chikatoshi Katada; Yasushi Sano; Atsushi Ohtsu; Hiroyasu Esumi; Satoshi Ebihara; Shigeaki Yoshida
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.